The imidazo-[1,2-a]-pyrazine (1) is a dual inhibitor of Aurora kinases A and B with modest cell potency (IC50 = 250 nM) and low solubility (5 μM). Lead optimization guided by the binding mode led to the acyclic amino alcohol 12k (SCH 1473759), which is a picomolar inhibitor of Aurora kinases (TdF K d Aur A = 0.02 nM and Aur B = 0.03 nM) with improved cell potency (phos-HH3 inhibition IC50 = 25 nM) and intrinsic aqueous solubility (11.4 mM). It also demonstrated efficacy and target engagement in human tumor xenograft mouse models.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007894 | PMC |
| http://dx.doi.org/10.1021/ml100063w | DOI Listing |
Publication Analysis
Top Keywords
inhibitor aurora
12
aurora kinases
12
cell potency
8
discovery potent
4
potent injectable
4
injectable inhibitor
4
kinases based
4
based imidazo-[12-a]-pyrazine
4
imidazo-[12-a]-pyrazine core
4
core imidazo-[12-a]-pyrazine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!